We just received data on a new analyst forecast for $GEN. Barclays gave a rating of 'Equal-Weight' for $GEN.
$GEN Analyst Ratings
Wall Street analysts have issued reports on $GEN in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Evercore ISI Group issued a "Outperform" rating on 07/01/2025
To track analyst ratings and price targets for $GEN, check out Quiver Quantitative's $GEN forecast page.
$GEN Price Targets
Multiple analysts have issued price targets for $GEN recently. We have seen 5 analysts offer price targets for $GEN in the last 6 months, with a median target of $33.0.
Here are some recent targets:
- Saket Kalia from Barclays set a target price of $33.0 on 08/08/2025
- Hal Goetsch from B. Riley Securities set a target price of $46.0 on 07/14/2025
- Robert Coolbrith from Evercore ISI Group set a target price of $35.0 on 07/01/2025
- Matthew Hedberg from RBC Capital set a target price of $30.0 on 05/07/2025
- Hamza Fodderwala from Morgan Stanley set a target price of $25.0 on 04/16/2025
$GEN Congressional Stock Trading
Members of Congress have traded $GEN stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $GEN stock by members of Congress over the last 6 months:
- REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 04/07.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$GEN Insider Trading Activity
$GEN insiders have traded $GEN stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $GEN stock by insiders over the last 6 months:
- NORA DENZEL sold 31,646 shares for an estimated $910,138
- NATALIE MARIE DERSE (CFO) sold 989 shares for an estimated $27,434
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$GEN Hedge Fund Activity
We have seen 336 institutional investors add shares of $GEN stock to their portfolio, and 305 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PACER ADVISORS, INC. removed 6,201,573 shares (-38.1%) from their portfolio in Q1 2025, for an estimated $164,589,747
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 3,724,211 shares (+43.6%) to their portfolio in Q1 2025, for an estimated $98,840,559
- BROWN ADVISORY INC removed 3,171,796 shares (-98.5%) from their portfolio in Q1 2025, for an estimated $84,179,465
- FIRST TRUST ADVISORS LP added 2,866,484 shares (+24.0%) to their portfolio in Q1 2025, for an estimated $76,076,485
- ALYESKA INVESTMENT GROUP, L.P. added 2,686,028 shares (+inf%) to their portfolio in Q1 2025, for an estimated $71,287,183
- VANGUARD GROUP INC added 2,513,464 shares (+3.7%) to their portfolio in Q1 2025, for an estimated $66,707,334
- FMR LLC added 2,486,404 shares (+7.8%) to their portfolio in Q1 2025, for an estimated $65,989,162
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
